Overview

Loxapine in the Management of Restlessness During Mechanical Ventilation Weaning

Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
This study aims to assess the efficacy of a drug (loxapine, a neuroleptic) in calming patients down in a situation of restlessness during mechanical ventilation weaning. This drug is used for several years to quieten restless patients. Its purpose is to restore spontaneous breathing sooner and therefore to reduce the risks of intubation and mechanical ventilation.
Phase:
Phase 4
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Treatments:
Loxapine